| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 773.47B | 777.10B | 602.32B | 424.06B | 216.14B |
| Gross Profit | 116.35B | 151.06B | 119.51B | 72.24B | 28.14B |
| EBITDA | 100.35B | 116.85B | 82.38B | 42.68B | 20.51B |
| Net Income | 31.77B | 40.25B | 30.04B | 16.62B | 3.05B |
Balance Sheet | |||||
| Total Assets | 890.31B | 783.36B | 679.55B | 493.86B | 295.78B |
| Cash, Cash Equivalents and Short-Term Investments | 139.20B | 143.25B | 118.66B | 72.10B | 56.06B |
| Total Debt | 165.42B | 30.24B | 39.15B | 15.36B | 22.41B |
| Total Liabilities | 650.40B | 584.67B | 529.09B | 372.47B | 191.54B |
| Stockholders Equity | 227.64B | 185.25B | 138.81B | 111.03B | 95.07B |
Cash Flow | |||||
| Free Cash Flow | -94.79B | 36.09B | 47.63B | 43.38B | 28.12B |
| Operating Cash Flow | 57.96B | 133.45B | 169.73B | 140.84B | 65.47B |
| Investing Cash Flow | -192.56B | -129.08B | -125.66B | -120.60B | -45.40B |
| Financing Cash Flow | 101.76B | -10.27B | 12.82B | -19.49B | 16.06B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$249.65B | 9.90 | 18.03% | 1.95% | 43.98% | -0.46% | |
64 Neutral | HK$967.40B | 24.33 | 14.29% | 1.55% | 3.62% | -22.00% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | HK$174.23B | 24.70 | 10.49% | 3.41% | 17.13% | -18.63% | |
60 Neutral | HK$121.68B | -5.74 | -984.82% | ― | 33.63% | 36.31% | |
56 Neutral | HK$122.67B | -122.26 | -3.77% | ― | 88.09% | 80.63% | |
52 Neutral | HK$142.74B | 107.16 | 1.55% | ― | -22.22% | -86.30% |